These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15316360)

  • 1. Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin.
    Ninova D; Covarrubias M; Rea DJ; Park WD; Grande JP; Stegall MD
    Transplantation; 2004 Aug; 78(3):338-44. PubMed ID: 15316360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats.
    Oğütmen B; Tuğlular S; Cakalağaoğlu F; Ozener C; Akoğlu E
    Transplant Proc; 2006 Mar; 38(2):487-9. PubMed ID: 16549155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model.
    Khanna AK; Pieper GM
    Nephrol Dial Transplant; 2007 Feb; 22(2):376-85. PubMed ID: 17085464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of an experimental rat model of tacrolimus-induced kidney injury accompanied by interstitial fibrosis.
    Fu R; Tajima S; Shigematsu T; Zhang M; Tsuchimoto A; Egashira N; Ieiri I; Masuda S
    Toxicol Lett; 2021 May; 341():43-50. PubMed ID: 33516819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
    Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
    Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathway.
    Djamali A; Vidyasagar A; Yagci G; Huang LJ; Reese S
    Transplantation; 2010 Aug; 90(4):387-93. PubMed ID: 20548261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
    Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR
    Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
    Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
    Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats.
    Deniz H; Oğütmen B; Cakalağaoğlu F; Tuğlular S; Ozener C; Akoğlu E
    Transplant Proc; 2006 Mar; 38(2):483-6. PubMed ID: 16549154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linagliptin ameliorates tacrolimus-induced renal injury: role of Nrf2/HO-1 and HIF-1α/CTGF/PAI-1.
    Nady ME; El-Raouf OMA; El-Sayed EM
    Mol Biol Rep; 2024 May; 51(1):608. PubMed ID: 38704766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.
    Fan JM; Ng YY; Hill PA; Nikolic-Paterson DJ; Mu W; Atkins RC; Lan HY
    Kidney Int; 1999 Oct; 56(4):1455-67. PubMed ID: 10504497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of core proteoglycan on the transdifferentiation of human renal tubular epithelial cell induced by transforming growth factor-beta1 in vitro].
    Cheng XQ; Bao HY; Chen Y; Pan XQ; Fei L; Chen RH
    Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):490-3. PubMed ID: 17953802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
    Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
    Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between transforming growth factor beta1 expression and cold ischemia injury of rat donor kidney.
    He W; Liu K; Ding H
    Exp Mol Pathol; 2010 Feb; 88(1):206-9. PubMed ID: 19874817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity.
    Ozdemir BH; Ozdemir FN; Demirhan B; Haberal M
    Transplantation; 2005 Dec; 80(12):1681-5. PubMed ID: 16378061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1.
    Wang HY; Wang YJ; Cui MJ; Gu CM; Yang LZ; Zhao Y; Chen Y; Zhao D; Li TS; Chi BR
    Indian J Biochem Biophys; 2011 Oct; 48(5):308-15. PubMed ID: 22165288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
    Matl I; Viklický O; Voska L; Lodererová A; Vítko S
    Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats.
    Shigematsu T; Tajima S; Fu R; Zhang M; Itoyama Y; Tsuchimoto A; Egashira N; Ieiri I
    Life Sci; 2022 Jan; 288():120150. PubMed ID: 34793770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.